Last $101.53 USD
Change Today -2.86 / -2.74%
Volume 574.9K
ALNY On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for alnylam pharmaceuticals inc (ALNY)

Currency in
Millions of US Dollars
As of:Dec 31
2011
Dec 31
2012
Reclassified
Dec 31
2013
Dec 31
2014
4 Year
Trend
NET INCOME-57.6-106.0-89.2-360.4
Depreciation & Amortization5.19.010.211.9
DEPRECIATION & AMORTIZATION, TOTAL5.19.010.211.9
(Gain) Loss on Sale of Investment0.6-16.3---2.1
Asset Writedown & Restructuring Costs------220.8
Other Operating Activities---10.6-2.7-40.2
(Income) Loss on Equity Investments3.54.5----
Tax Benefit from Stock Options0.1------
Change in Accounts Receivable2.01.4-4.1-35.7
Change in Accounts Payable-3.5-1.71.88.8
Change in Unearned Revenues-70.3-8.6-6.2-7.8
Change in Income Taxes10.7------
Change in Other Working Capital5.20.00.45.2
CASH FROM OPERATIONS-87.1-115.6-68.7-165.6
Capital Expenditure-1.3-8.3-4.0-9.0
Cash Acquisitions-------25.0
Investments in Marketable & Equity Securities83.311.9-126.5-514.9
CASH FROM INVESTING82.03.4-130.5-548.8
Issuance of Common Stock0.793.8202.3752.5
Repurchase of Common Stock---0.4-1.4-16.0
CASH FROM FINANCING0.793.4200.9736.5
NET CHANGE IN CASH-4.4-18.81.822.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALNY:US $101.53 USD -2.86

ALNY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Benitec Biopharma Ltd A$0.86 AUD -0.025
Enzon Pharmaceuticals Inc $1.05 USD -0.04
Galena Biopharma Inc $1.80 USD -0.03
Silence Therapeutics PLC 248.00 GBp -2.00
Tekmira Pharmaceuticals Corp C$22.55 CAD -0.34
View Industry Companies
 

Industry Analysis

ALNY

Industry Average

Valuation ALNY Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 154.5x
Price/Book 8.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 154.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALNYLAM PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.